To find compounds like small molecules, peptides, or RNAi that change the phenotype of a cell or an organism in a desirable way, phenotypic screening is a sort of screening used in biological research and drug development. To understand how a phenotypic hit functions, phenotypic screening must be followed by identification and confirmation, frequently using chemoproteomics. Historically, medication discovery has been based on phenotypic screening. Compounds are tested in cellular or animal illness models to find those that result in a desired change in phenotype. The procedure of target deconvolution is used to identify the biological targets of chemicals only after they have been found. This comprehensive plan is known as target deconvolution. This overall strategy is referred to as "classical pharmacology", "forward pharmacology" or "phenotypic drug discovery" (PDD).
Title : The impact of AI on the future of public health and preventative healthcare
David John Wortley, International Society of Digital Medicine (ISDM), United Kingdom
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, National Center for Human Photosynthesis, Mexico
Title : Managing integration and interoperability of intelligent and ethical transformed health and social care ecosystems
Habil Bernd Blobel, University of Regensburg, Germany
Title : Study scalp electroacupuncture therapy for autism spectrum disorder
Zhenhuan Liu, University of Chinese Medicine, China
Title : Environmental Public Health Impact Assessment (EHIA) process for tobacco processing plants
Vijayan Gurumurthy Iyer, Techno-Economic- Environmental Study and Check Consultancy Services, India
Title : Therapeutic potential of Benincasa hispida extract in regulating metabolic markers among patients with type 2 diabetes
Wan Rosli Wan Ishak , University Science Malaysia, Malaysia